Low hematocrit leading to tacrolimus toxicity

被引:0
|
作者
Piletta-Zanin, A. [1 ,2 ]
De Mul, A. [2 ]
Rock, N. [2 ]
Lescuyer, P. [3 ]
Samer, C. F. [1 ,4 ]
Rodieux, F. [1 ]
机构
[1] Geneva Univ Hosp, Div Clin Pharmacol & Toxicol, Dept Anesthesiol Pharmacol Intens Care & Emergenc, Geneva, Switzerland
[2] Geneva Univ Hosp, Div Pediat Specialties, Dept Women Children & Adolescents, Geneva, Switzerland
[3] Geneva Univ Hosp, Div Lab Med, Dept Diagnost, Geneva, Switzerland
[4] Univ Geneva, Inst Pharmaceut Sci Western Switzerland ISPSO, Geneva, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P 5
引用
收藏
页码:16 / 16
页数:1
相关论文
共 50 条
  • [1] Low hematocrit leading to tacrolimus toxicity
    Piletta-Zanin, A.
    De Mul, A.
    Rock, N.
    Lescuyer, P.
    Samer, C. F.
    Rodieux, F.
    SWISS MEDICAL WEEKLY, 2021, 151 : 16S - 16S
  • [2] Case Report: Low Hematocrit Leading to Tacrolimus Toxicity
    Piletta-Zanin, Alexandre
    De Mul, Aurelie
    Rock, Nathalie
    Lescuyer, Pierre
    Samer, Caroline F.
    Rodieux, Frederique
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [3] Importance of hematocrit for a tacrolimus target concentration strategy
    Elisabet Størset
    Nick Holford
    Karsten Midtvedt
    Sara Bremer
    Stein Bergan
    Anders Åsberg
    European Journal of Clinical Pharmacology, 2014, 70 : 65 - 77
  • [4] Importance of hematocrit for a tacrolimus target concentration strategy
    Storset, Elisabet
    Holford, Nick
    Midtvedt, Karsten
    Bremer, Sara
    Bergan, Stein
    Asberg, Anders
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (01) : 65 - 77
  • [5] Correlation of Hematocrit and Tacrolimus Level in Liver Transplant Recipients
    Limsrichamrern, S.
    Chanapul, C.
    Mahawithitwong, P.
    Sirivatanauksorn, Y.
    Kositamongkol, P.
    Asavakarn, S.
    Tovikkai, C.
    Dumronggittigule, W.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (04) : 1176 - 1178
  • [6] Evaluation of three immunoassays to quantify tacrolimus: Impact of hematocrit
    Goffinet, Jean-Sebatien
    Mullier, Francois
    Capron, Arnaud
    Cumps, Jean
    Wallemacq, Pierre
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 508 - 508
  • [7] Interference of hematocrit in the tacrolimus II microparticle enzyme immunoassay
    Kuzuya, T
    Ogura, Y
    Motegi, Y
    Moriyama, N
    Nabeshima, T
    THERAPEUTIC DRUG MONITORING, 2002, 24 (04) : 507 - 511
  • [8] CYP3A5 Polymorphisms Leading to Tacrolimus Toxicity Following an Adult Renal Transplant
    Alotaibi, Nouf
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2023, 34 (03) : 250 - 253
  • [10] Hematocrit influences immunoassay performance for the measurement of tacrolimus in whole blood
    Armendáriz, Y
    García, S
    Lopez, RM
    Pou, L
    THERAPEUTIC DRUG MONITORING, 2005, 27 (06) : 766 - 769